Outcome and safety of intraoperative tranexamic acid use in reducing blood loss during transurethral resection of the prostate for benign prostatic hyperplasia: a case controlled study
Research Journal of Health Sciences · 25.06.2026 · 14 (2) · 88-95
DOI: 10.4314/rejhs.v14i2.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Journal of Health Sciences, online erschienen am 25.06.2026. Verfasst von E. Ozah und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
TURP is the gold standard surgical treatment for BPH. Among its complications include bleeding. Several measures have been instituted to mitigate it. Currently, the efficacy of tranexamic acid is being investigated. This study aims to assess outcome and safety of tranexamic acid use in TURP for BPH.
Methods
This a case-controlled study involving patients who had tranexamic acid administered intravenously and a group that did not have it during TURP from January 2022 to October 2025. Electronic medical records of 60 patients were retrieved retrospectively, data entered in a proforma. Data were analyzed with SPSS version 25.0. P-value less than 0.05 was considered significant.
Results
Most patients, in this study were >60 years, 24(80%) patients in each group and the age distribution did not differ significantly (p= 0.837). There was no significant difference in intraoperative transfusion between the two groups(p= 0.084), even though tranexamic acid group had less transfusion, while multiple transfusions were significantly less in tranexamic acid group (p=0.04). Postoperative transfusion was insignificant between the two groups (p= 0.279). The mean change in hemoglobin post TURP was also not statistically significant (p=0.247). The mean duration of hospital stay was insignificant between both groups (p=0.770). Only minor side effects were recorded with use of tranexamic acid. The commonest was nausea and vomiting in 3(42.9%) patients.
Conclusion
There was less blood loss with tranexamic acid use in TURP with safe outcome.
Zitieren
APA
Ozah, E., & Osaigbovo, E. (2026). Outcome and safety of intraoperative tranexamic acid use in reducing blood loss during transurethral resection of the prostate for benign prostatic hyperplasia: a case controlled study. Research Journal of Health Sciences, 14(2), 88-95. https://doi.org/10.4314/rejhs.v14i2.2
Vancouver
Ozah E, Osaigbovo E. Outcome and safety of intraoperative tranexamic acid use in reducing blood loss during transurethral resection of the prostate for benign prostatic hyperplasia: a case controlled study. Research Journal of Health Sciences. 2026;14(2):88-95. doi:10.4314/rejhs.v14i2.2
BibTeX
@article{Ozah2026,
author = {Ozah, E. and Osaigbovo, E.O.},
title = {Outcome and safety of intraoperative tranexamic acid use in reducing blood loss during transurethral resection of the prostate for benign prostatic hyperplasia: a case controlled study},
journal = {Research Journal of Health Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {88--95},
doi = {10.4314/rejhs.v14i2.2}
}
EUVIMED